SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study
Plasma SARS-CoV-2 RNA seems to be associated with a worse COVID-19 outcome. Viremic patients were more frequently affected by hematological malignancies and had a higher viral load in respiratory samples
